Literature DB >> 14694099

The spacing between cysteines two and three of the LDL-A module of Tva is important for subgroup A avian sarcoma and leukosis virus entry.

Tia Rai1, Deborah Marble, Kayla Rihani, Lijun Rong.   

Abstract

Rong et al. have demonstrated previously that with a few substitutions, the fourth repeat of human low-density lipoprotein (hLDL-A4) receptor can functionally replace the LDL-A module of Tva, the cellular receptor for subgroup A avian sarcoma and leukosis virus (ASLV-A), in viral entry (L. Rong, K. Gendron, and P. Bates, Proc. Natl. Acad. Sci. USA 95:8467-8472, 1998). Here we have shown that swapping the amino terminus of hLDL repeat 5 (hLDL-A5) with that of Tva, in addition to the corresponding substitutions made in human LDL-A4, was required to convert hLDL-A5 into an efficient ASLV-A receptor. These results substantiated our previous findings regarding the role of the specific residues in the viral interaction domain of Tva and demonstrated the critical role of the amino terminus of the Tva LDL-A module in ASLV-A infection. Furthermore, we have shown that the residues between cysteines 2 and 3 of the Tva LDL-A module in a Tva/LDL-A5 chimeric protein can be functionally replaced by the corresponding region of another LDL-A module, human LDL receptor-related protein repeat 22 (LDL-A22), to mediate efficient ASLV-A entry. Since the only conserved feature between the C2-C3 region of LDL-A22 and the Tva LDL-A module is that both contain nine amino acids of which none are conserved, we conclude that the spacing between C2 and C3 of the LDL-A module of Tva is an important determinant for ASLV-A entry. Thus, the present study provides strong evidence to support our hypothesis that one role of the N terminus of the LDL-A module of Tva is to allow proper folding and conformation of the protein for optimal interaction with the viral glycoprotein EnvA in ASLV-A entry.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14694099      PMCID: PMC368809          DOI: 10.1128/jvi.78.2.683-691.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

2.  Identification and characterization of the viral interaction determinant of the subgroup A avian leukosis virus receptor.

Authors:  K Zingler; C a Bélanger; R Peters; E Agard; J A Young
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

3.  Calcium coordination and pH dependence of the calcium affinity of ligand-binding repeat CR7 from the LRP. Comparison with related domains from the LRP and the LDL receptor.

Authors:  M Simonovic; K Dolmer; W Huang; D K Strickland; K Volz; P G Gettins
Journal:  Biochemistry       Date:  2001-12-18       Impact factor: 3.162

4.  Three-dimensional structure of the second cysteine-rich repeat from the human low-density lipoprotein receptor.

Authors:  N L Daly; J T Djordjevic; P A Kroon; R Smith
Journal:  Biochemistry       Date:  1995-11-07       Impact factor: 3.162

5.  Importance of cysteines in the LDLR-related domain of the subgroup A avian leukosis and sarcoma virus receptor for viral entry.

Authors:  C Bélanger; K Zingler; J A Young
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

6.  Analysis of the subgroup A avian sarcoma and leukosis virus receptor: the 40-residue, cysteine-rich, low-density lipoprotein receptor repeat motif of Tva is sufficient to mediate viral entry.

Authors:  L Rong; P Bates
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

7.  Three-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor.

Authors:  N L Daly; M J Scanlon; J T Djordjevic; P A Kroon; R Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

8.  Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.

Authors:  R I Connor; B K Chen; S Choe; N R Landau
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

9.  A soluble form of a receptor for subgroup A avian leukosis and sarcoma viruses (ALSV-A) blocks infection and binds directly to ALSV-A.

Authors:  L Connolly; K Zingler; J A Young
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein.

Authors:  J M Gilbert; L D Hernandez; J W Balliet; P Bates; J M White
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  4 in total

1.  Identification of two residues within the LDL-A module of Tva that dictate the altered receptor specificity of mutant subgroup A avian sarcoma and leukosis viruses.

Authors:  Tia Rai; Michael Caffrey; Lijun Rong
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  The avian retroviral receptor Tva mediates the uptake of transcobalamin bound vitamin B12 (cobalamin).

Authors:  Veronika Krchlíková; Jana Mikešová; Josef Geryk; Cyril Bařinka; Ebba Nexo; Sergey N Fedosov; Jan Kosla; Dana Kučerová; Markéta Reinišová; Jiří Hejnar; Daniel Elleder
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

Review 3.  Advances on genetic and genomic studies of ALV resistance.

Authors:  Guodong Mo; Ping Wei; Bowen Hu; Qinghua Nie; Xiquan Zhang
Journal:  J Anim Sci Biotechnol       Date:  2022-10-11

4.  SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion.

Authors:  Ikenna G Madu; Sandrine Belouzard; Gary R Whittaker
Journal:  Virology       Date:  2009-08-29       Impact factor: 3.616

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.